Coronavirus can eliminate testosterone levels, success study suggests

MERSIN, Turkey – During this epidemic, it has been repeatedly said that men are at greater risk of severe symptoms of COVID than women. However, scientists are at a loss as to why. Now, for the first time, a new study has found that COVID-19 can actually lower men’s testosterone levels.

The study was conducted at Mersin University and Mersin City Education and Research Hospital. Researchers say that as a male patient’s baseline testosterone levels (taken at hospital admission) steadily decrease, the likelihood of being placed in ICU care increases. In addition, more than half of the male patients studied had low average testosterone levels.

This is not the first time that low testosterone levels are identified as a risk factor for severe coronavirus symptoms. However, this is the first piece of research that a COVID-19 infection actively lowers a man’s testosterone levels.

COVID effect on testosterone may solve mystery

Although nothing has been confirmed yet, the study’s authors are optimistic that they have answered the question of why men are seeing more severe symptoms than women. In addition, this finding opens the door for a testosterone-based coronavirus treatment approach.

“Testosterone is linked to the immune system of the respiratory organs, and low levels of testosterone may increase the risk of respiratory infections. Low testosterone is also a cause of infection-related hospitalization and mortality in men in ICU patients, so testosterone treatment may also have benefits beyond improving COVID-19 results, ”lead study author Selahitin inayan, Professor of Urology, one says skip.

“In our study, average testosterone decreased as COVID-19 increased in severity. Average testosterone levels were significantly lower in the ICU group than in the asymptomatic group. In addition, average total testosterone levels were significantly lower in the ICU group than in the intermediate care unit group. Serum follicle stimulating hormone levels were significantly higher in the ICU group than in the asymptomatic group, ”she continues.

Even asymptomatic patients have symptoms.

All in all, the study includes data from 438 participants. All tests were positive for COVID-19 and 232.

Hypogonadism One condition means that one’s body does not produce enough testosterone that was seen in a total of 113 (51.1%) male patients. A total of 11 male patients died, along with seven female patients.

“Patients who died had lower total testosterone than live patients. However, 65.2% of the 46 male patients who were asymptomatic have loss of libido, ”says Professor% Narayan.

“It can be recommended that at the time of COVID-19 diagnosis, testosterone levels are also tested. In men with low levels of sex hormones testing positive for COVID-19, testosterone treatment may improve their prognosis. More research is needed on this, ”Professor Isin concluded.

The study is published in Old man

Leave a Reply

Your email address will not be published.